title: Daratumumab (anti-CD38) induces loss of CD38 on red blood cells.
authors.affiliation: Center for Transfusion Medicine and Cellular Therapies, Department of Pathology and Laboratory Medicine.
authors.forename: Harold C
authors.initials: HC
authors.lastname: Sullivan
authors.affiliation: Center for Transfusion Medicine and Cellular Therapies, Department of Pathology and Laboratory Medicine.
authors.forename: Christian
authors.initials: C
authors.lastname: Gerner-Smidt
authors.affiliation: Department of Hematology and Medical Oncology, and.
authors.forename: Ajay K
authors.initials: AK
authors.lastname: Nooka
authors.affiliation: Center for Transfusion Medicine and Cellular Therapies, Department of Pathology and Laboratory Medicine.
authors.forename: Connie M
authors.initials: CM
authors.lastname: Arthur
authors.affiliation: Center for Transfusion Medicine and Cellular Therapies, Department of Pathology and Laboratory Medicine.
authors.forename: Louisa
authors.initials: L
authors.lastname: Thompson
authors.affiliation: Center for Transfusion Medicine and Cellular Therapies, Department of Pathology and Laboratory Medicine.
authors.forename: Amanda
authors.initials: A
authors.lastname: Mener
authors.affiliation: Center for Transfusion Medicine and Cellular Therapies, Department of Pathology and Laboratory Medicine.
authors.forename: Seema R
authors.initials: SR
authors.lastname: Patel
authors.affiliation: Department of Pediatrics, Emory University School of Medicine, Atlanta, GA; and.
authors.forename: Marianne
authors.initials: M
authors.lastname: Yee
authors.affiliation: Center for Transfusion Medicine and Cellular Therapies, Department of Pathology and Laboratory Medicine.
authors.forename: Ross M
authors.initials: RM
authors.lastname: Fasano
authors.affiliation: Center for Transfusion Medicine and Cellular Therapies, Department of Pathology and Laboratory Medicine.
authors.forename: Cassandra D
authors.initials: CD
authors.lastname: Josephson
authors.affiliation: Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
authors.forename: Richard M
authors.initials: RM
authors.lastname: Kaufman
authors.affiliation: Center for Transfusion Medicine and Cellular Therapies, Department of Pathology and Laboratory Medicine.
authors.forename: John D
authors.initials: JD
authors.lastname: Roback
authors.affiliation: Department of Hematology and Medical Oncology, and.
authors.forename: Sagar
authors.initials: S
authors.lastname: Lonial
authors.affiliation: Center for Transfusion Medicine and Cellular Therapies, Department of Pathology and Laboratory Medicine.
authors.forename: Sean R
authors.initials: SR
authors.lastname: Stowell
mesh_terms: D051997:ADP-ribosyl Cyclase 1 / Q000097:blood*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects*; D004912:Erythrocytes / Q000378:metabolism / Q000473:pathology; D005260:Female; D006801:Humans; D008297:Male; D008562:Membrane Glycoproteins / Q000097:blood*; D009101:Multiple Myeloma / Q000097:blood / Q000178:diet therapy / Q000473:pathology
chemical_list: D000911:Antibodies, Monoclonal; D008562:Membrane Glycoproteins; C556306:daratumumab; C498154:CD38 protein, human; D051997:ADP-ribosyl Cyclase 1